China indicates no relaxation of restrictions to 'zero-Covid' policy

Scattered outbreaks across the country continue to prompt travel restrictions and lockdowns

China flag
(Photo: Reuters)
AP Beijing
2 min read Last Updated : Nov 05 2022 | 5:07 PM IST

Chinese health officials gave no indication on Saturday of any relaxation of COVID-19 restrictions, following several days of speculation that the government was considering changes to a zero-COVID approach that has stymied economic growth and disrupted daily life.

The officials said at a news conference that they would unswervingly stick to the policy, which seeks to stop cases from coming into the country and snuff out outbreaks as they occur.

The announcement was not a surprise and doesn't rule out the possibility that discussions are taking place behind closed doors.

But there has been no official confirmation, and most analysts believe that any change will be gradual and major easing is unlikely until sometime next year.

The speculation rallied stock markets in China this week, with investors as well as the public latching onto any hints of possible change.

The death of a 3-year-old boy in a quarantined residential compound fuelled growing discontent with the China's anti-virus controls, which are increasingly out of step with the rest of the world.

Scattered outbreaks across the country continue to prompt travel restrictions and lockdowns.

China on Saturday reported identifying about 3,500 new cases the previous day, including about 3,000 who tested positive despite not having any COVID-19 symptoms.

In the city of Guangzhou in the southeast, Haizhu district suspended bus and subway service for three days and urged residents to stay home as it conducts mass testing of its 1.8 million people.

One person per household is allowed out each day to shop for necessities.

Restrictions are also in place in parts of the Inner Mongolia region in the north and the Xinjiang region in the west, where 43 new high-risk areas were designated Saturday in Urumqi, the regional capital.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusChinaCoronavirus Tests

First Published: Nov 05 2022 | 5:07 PM IST

Next Story